Neuberger Berman Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Neuberger Berman Group's RYTM Position: Q3 2026 in Review
Neuberger Berman Group increased its Rhythm Pharmaceuticals (RYTM) stake by 0.23% in Q3 2026, buying an estimated $20.1K and bringing the position to 83,223 shares worth $7.92M. The position accounts for 0.01% of the portfolio, ranked #930.
Neuberger Berman Group first reported a position in RYTM in Q1 2025 and has held it in 7 quarters since. The position peaked at $9.22M in Q2 2026. 332 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Neuberger Berman Group held 83,223 shares of Rhythm Pharmaceuticals worth $7.92M as of Q3 2026.
- Neuberger Berman Group bought 188 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $20.1K.
- Rhythm Pharmaceuticals made up 0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #930 holding.
- Neuberger Berman Group first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- Neuberger Berman Group's Rhythm Pharmaceuticals position peaked at $9.22M in Q2 2026.
- 332 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.